Lili Niu

机构：University of Copenhagen, Novo Nordisk (Denmark), Novo Nordisk Foundation, Sichuan Agricultural University, Max Planck Institute of Biochemistry · ORCID：0000-0003-4571-4368

发表论文 109 篇 · 总被引 3593 次 · h-index 26

代表论文

• Taking SCFAs produced by Lactobacillus reuteri orally reshapes gut microbiota and elicits antitumor responses (2024 · Journal of Nanobiotechnology · 被引 70)
• Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases (2024 · Journal of Hepatology · 被引 59)
• Imputation of label-free quantitative mass spectrometry-based proteomics data using self-supervised deep learning (2024 · Nature Communications · 被引 55)
• Plasma proteome variation and its genetic determinants in children and adolescents (2025 · Nature Genetics · 被引 49)
• Bridging the Gap From Proteomics Technology to Clinical Application: Highlights From the 68th Benzon Foundation Symposium (2024 · Molecular & Cellular Proteomics · 被引 28)
• Oral probiotics microgel plus Galunisertib reduced TGF-β blockade resistance and enhanced anti-tumor immune responses in colorectal cancer (2024 · International Journal of Pharmaceutics · 被引 26)